Click Here: TYNKR LAB™ The U.S. stock markets closed in negative territory as tech shares faced selling pressure, and rising Treasury yields added to the cautious sentiment.$Dow Jones Industrial Average (.DJI.US)$fell by 0.22%,$S&P 500 Index (.SPX.US)$lost 0.33%, and$Nasdaq Composite Index (.IXIC.US)$declined by 0.49%. This downturn highlights investor apprehension driven by economic concerns and mixed corporate earnings results, pa...
The market generally closed positively on Tuesday, though indexes were weighed down. The tech-heavy Nasdaq index fell from earnings reactions and a pullback in Semiconductors. Past the closing bell PM EST, the$S&P 500 Index (.SPX.US)$climbed 0.13%, the$Dow Jones Industrial Average (.DJI.US)$climbed 0.18%, and the$Nasdaq Composite Index (.IXIC.US)$fell about 0.10%. MACRO Fed's Kashkari said that one rate cut is still possible this year, whic...
The Warlock
Pr3car1ous
:
reality and facts has a liberal bias. get yourself out of your bubble and you'll learn that feelings don't count for much in this world
Morning mooers, happy Tuesday. It is May 7th, the market is open, and equities are climbing. It is a beautiful spring day in Jersey City, my name is Kevin Travers, and here are stories moving the market today: MOOVERS $FMC Corp (FMC.US)$ led the S&P 500, up 8% after the firm's morning earnings showed a GAAP loss $3 million and revenue down 32% year-over-year. Shares of $Palantir (PLTR.US)$ fell 14% despite reporting first-quarter revenue tha...
FMC's share price drop, despite improved EPS, may be due to weak revenue. The company's underperformance over the past year and worse than 5% annualised loss over the last half decade indicate unresolved challenges.
Analysts express disappointment in FMC's 2024 guidance, implying flat earnings. They anticipate company-specific challenges to weigh on shares until mid-2024 when volumes and margins are expected to improve.
The stock's current price is stable and relatively cheap, indicating high growth potential. The buoyant future profit outlook suggests it might be a good time to invest in FMC.
$FMC Corp (FMC.US)$interesting upcoming ipo. Late stage for Non-Muscle invasive bladder cancer The company is evaluating cretostimogene as a monotherapy in BOND-003, its ongoing Phase 3 trial in high-risk BCG-unresponsive NMIBC patients, and expects to report topline data by the end of 2024
FMC's lower P/E ratio points to forecasted growth lagging the market. Investors anticipate minimal future growth, pricing the stock lower. Hence, a substantial increase in share price is improbable soon.
Morning Movers Gapping up $Occidental Petroleum (OXY.US)$Berkshire Hathaway has acquired nearly 10.5 million shares of Occidental Petroleum so far this week for about $588.7 million, according to a filing at the U.S. Securities and Exchange Commission on Wednesday. The purchases bring Berkshire's stake in Occidental to about 27%. Shares of OXY rose by 1.92% in premarket trading. $Moderna (MRNA.US)$shares rose more than 4% in pr...
Analysts are more bearish on FMC's outlook, anticipating a steep fall in revenues and EPS. FMC's projected revenue performance is much worse than the wider industry, creating potential caution from the market. Yet, the general future direction of the company is more crucial for shareholders.
FMC Corp Stock Forum
The U.S. stock markets closed in negative territory as tech shares faced selling pressure, and rising Treasury yields added to the cautious sentiment. $Dow Jones Industrial Average (.DJI.US)$ fell by 0.22%, $S&P 500 Index (.SPX.US)$ lost 0.33%, and $Nasdaq Composite Index (.IXIC.US)$ declined by 0.49%. This downturn highlights investor apprehension driven by economic concerns and mixed corporate earnings results, pa...
Past the closing bell PM EST, the $S&P 500 Index (.SPX.US)$ climbed 0.13%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 0.18%, and the $Nasdaq Composite Index (.IXIC.US)$ fell about 0.10%.
MACRO
Fed's Kashkari said that one rate cut is still possible this year, whic...
It is a beautiful spring day in Jersey City, my name is Kevin Travers, and here are stories moving the market today:
MOOVERS
$FMC Corp (FMC.US)$ led the S&P 500, up 8% after the firm's morning earnings showed a GAAP loss $3 million and revenue down 32% year-over-year.
Shares of $Palantir (PLTR.US)$ fell 14% despite reporting first-quarter revenue tha...
The company is evaluating cretostimogene as a monotherapy in BOND-003, its ongoing Phase 3 trial in high-risk BCG-unresponsive NMIBC patients, and expects to report topline data by the end of 2024
Gapping up
$Occidental Petroleum (OXY.US)$ Berkshire Hathaway has acquired nearly 10.5 million shares of Occidental Petroleum so far this week for about $588.7 million, according to a filing at the U.S. Securities and Exchange Commission on Wednesday.
The purchases bring Berkshire's stake in Occidental to about 27%. Shares of OXY rose by 1.92% in premarket trading.
$Moderna (MRNA.US)$ shares rose more than 4% in pr...
No comment yet